Sarah
A.
Abramowitz,
BA;
Kristin
Boulier,
MD;
Karl
Keat,
BS;
Katie
M.
Cardone,
Manu
Shivakumar,
John
DePaolo,
MD,
PhD;
Renae
Judy,
MS;
Francisca
Bermudez,
Nour
Mimouni,
Christopher
Neylan,
Dokyoon
Kim,
Daniel
J.
Rader,
Marylyn
D.
Ritchie,
Benjamin
F.
Voight,
Bogdan
Pasaniuc,
Michael
G.
Levin,
Scott
Damrauer,
Penn
Medicine
BioBank;
J
Rader;
D
Ritchie;
JoEllen
Weaver;
Nawar
Naseer;
Giorgio
Sirugo;
Afiya
Poindexter;
Yi-An
Ko;
Kyle
P.
Nerz;
Meghan
Livingstone;
Fred
Vadivieso;
Stephanie
DerOhannessian;
Teo
Tran;
Julia
Stephanowski;
Salma
Santos;
Ned
Haubein;
Joseph
Dunn;
Anurag
Verma;
Colleen
Kripke;
Marjorie
Risman;
Judy;
Colin
Wollack;
Shefali
S.
M
Damrauer;
Yuki
Bradford;
Dudek;
Theodore
Drivas
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 24, 2024
Polygenic
risk
scores
(PRS)
continue
to
improve
with
novel
methods
and
expanding
genome-wide
association
studies.
Healthcare
commercial
laboratories
are
increasingly
deploying
PRS
reports
patients,
but
it
is
unknown
how
the
classification
of
high
polygenic
changes
across
individual
PRS.
Here,
we
assessed
performance
cataloged
for
three
complex
traits.
We
chronologically
ordered
all
trait-related
publications
(Pub
Clinical Cardiology,
Год журнала:
2024,
Номер
47(9)
Опубликована: Сен. 1, 2024
ABSTRACT
Background
Young
adults
with
elevated
LDL‐C
may
experience
increased
burden
of
additional
cardiovascular
disease
(CVD)
risk
factors.
It
is
unclear
how
much
levels,
a
modifiable
factor,
correlate
non‐LDL‐C
CVD
factors
among
young
or
strongly
these
are
associated
long‐term
predicted
risk.
We
quantified
clustering
by
to
assess
the
association
between
and
in
adults.
Methods
The
current
analysis
cross‐sectional
study
<
40
years
an
LDL‐C<
190
mg/dL
participating
National
Health
Nutrition
Examination
Survey
(NHANES)
January
2015
March
2020.
measured
prevalence
Predicting
Risk
EVENTs
(PREVENT)
equations.
Results
Among
2108
adults,
≥
130
was
15.5%.
Compared
100
mg/dL,
those
100–<
130,
130–<
160,
160–<
had
greater
Both
were
independently
30‐year
(OR
1.05,
95%
CI
1.03–1.07
OR
1.17,
1.12–1.23,
respectively).
did
not
vary
factor
(
p
interaction
=
0.43).
Conclusion
Non‐LDL‐C
cluster
increasing
levels
Greater
guidance
on
manage
needed.
Sarah
A.
Abramowitz,
BA;
Kristin
Boulier,
MD;
Karl
Keat,
BS;
Katie
M.
Cardone,
Manu
Shivakumar,
John
DePaolo,
MD,
PhD;
Renae
Judy,
MS;
Francisca
Bermudez,
Nour
Mimouni,
Christopher
Neylan,
Dokyoon
Kim,
Daniel
J.
Rader,
Marylyn
D.
Ritchie,
Benjamin
F.
Voight,
Bogdan
Pasaniuc,
Michael
G.
Levin,
Scott
Damrauer,
Penn
Medicine
BioBank;
J
Rader;
D
Ritchie;
JoEllen
Weaver;
Nawar
Naseer;
Giorgio
Sirugo;
Afiya
Poindexter;
Yi-An
Ko;
Kyle
P.
Nerz;
Meghan
Livingstone;
Fred
Vadivieso;
Stephanie
DerOhannessian;
Teo
Tran;
Julia
Stephanowski;
Salma
Santos;
Ned
Haubein;
Joseph
Dunn;
Anurag
Verma;
Colleen
Kripke;
Marjorie
Risman;
Judy;
Colin
Wollack;
Shefali
S.
M
Damrauer;
Yuki
Bradford;
Dudek;
Theodore
Drivas